APO Research
Talk to an analyst

APO RESEARCH · REPORT

Capecitabine Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Capecitabine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchCapecitabine Tablets Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Capecitabine Tablets Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Capecitabine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Capecitabine Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Capecitabine Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Capecitabine Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Capecitabine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Capecitabine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Capecitabine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Capecitabine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Capecitabine Tablets include Chia Tai-Tianqing Pharmaceutical, Chengdu Easton Biopharmaceuticals, Shanghai Sine Pharmaceutical, Shandong New Time Pharmaceutical, Qilu Pharmaceutical, Roche, Teva Pharmaceutical, Sun Pharma and Eugia Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Capecitabine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Capecitabine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Capecitabine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Capecitabine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Capecitabine Tablets Segment by Company

Chia Tai-Tianqing Pharmaceutical

Chengdu Easton Biopharmaceuticals

Shanghai Sine Pharmaceutical

Shandong New Time Pharmaceutical

Qilu Pharmaceutical

Roche

Teva Pharmaceutical

Sun Pharma

Eugia Pharma

Dr. Reddy's Laboratories

Accord Healthcare

Capecitabine Tablets Segment by Type

150mg

500mg

Capecitabine Tablets Segment by Application

Colon Cancer

Breast Cancer

Stomach Cancer

Capecitabine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Capecitabine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Capecitabine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Capecitabine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Capecitabine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Capecitabine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Capecitabine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Capecitabine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Capecitabine Tablets Industry Trends Table 2. Capecitabine Tablets Industry Drivers Table 3. Capecitabine Tablets Industry Opportunities and Challenges Table 4. Capecitabine Tablets Industry Restraints Table 5. Global Capecitabine Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Capecitabine Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Capecitabine Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Capecitabine Tablets Sales Market Share by Manufacturers Table 9. Global Capecitabine Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Capecitabine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Capecitabine Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Capecitabine Tablets Manufacturers, Product Type & Application Table 13. Global Capecitabine Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Capecitabine Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 150mg Table 17. Major Manufacturers of 500mg Table 18. Global Capecitabine Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Capecitabine Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Capecitabine Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Capecitabine Tablets Sales Market Share by Type (2021-2026) Table 22. Global Capecitabine Tablets Sales Market Share by Type (2027-2032) Table 23. Global Capecitabine Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Capecitabine Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Capecitabine Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Capecitabine Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Capecitabine Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Colon Cancer Table 29. Major Manufacturers of Breast Cancer Table 30. Major Manufacturers of Stomach Cancer Table 31. Global Capecitabine Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Capecitabine Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Capecitabine Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Capecitabine Tablets Sales Market Share by Application (2021-2026) Table 35. Global Capecitabine Tablets Sales Market Share by Application (2027-2032) Table 36. Global Capecitabine Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Capecitabine Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Capecitabine Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Capecitabine Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Capecitabine Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Capecitabine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Capecitabine Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Capecitabine Tablets Sales Market Share by Region (2021-2026) Table 44. Global Capecitabine Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Capecitabine Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Capecitabine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Capecitabine Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Capecitabine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Capecitabine Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Capecitabine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Capecitabine Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Capecitabine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Capecitabine Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Capecitabine Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Capecitabine Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Capecitabine Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Capecitabine Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Capecitabine Tablets Revenue Market Share by Region (2027-2032) Table 63. Chia Tai-Tianqing Pharmaceutical Company Information Table 64. Chia Tai-Tianqing Pharmaceutical Business Overview Table 65. Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product Portfolio Table 67. Chia Tai-Tianqing Pharmaceutical Recent Development Table 68. Chengdu Easton Biopharmaceuticals Company Information Table 69. Chengdu Easton Biopharmaceuticals Business Overview Table 70. Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product Portfolio Table 72. Chengdu Easton Biopharmaceuticals Recent Development Table 73. Shanghai Sine Pharmaceutical Company Information Table 74. Shanghai Sine Pharmaceutical Business Overview Table 75. Shanghai Sine Pharmaceutical Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shanghai Sine Pharmaceutical Capecitabine Tablets Product Portfolio Table 77. Shanghai Sine Pharmaceutical Recent Development Table 78. Shandong New Time Pharmaceutical Company Information Table 79. Shandong New Time Pharmaceutical Business Overview Table 80. Shandong New Time Pharmaceutical Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shandong New Time Pharmaceutical Capecitabine Tablets Product Portfolio Table 82. Shandong New Time Pharmaceutical Recent Development Table 83. Qilu Pharmaceutical Company Information Table 84. Qilu Pharmaceutical Business Overview Table 85. Qilu Pharmaceutical Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Qilu Pharmaceutical Capecitabine Tablets Product Portfolio Table 87. Qilu Pharmaceutical Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Roche Capecitabine Tablets Product Portfolio Table 92. Roche Recent Development Table 93. Teva Pharmaceutical Company Information Table 94. Teva Pharmaceutical Business Overview Table 95. Teva Pharmaceutical Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Teva Pharmaceutical Capecitabine Tablets Product Portfolio Table 97. Teva Pharmaceutical Recent Development Table 98. Sun Pharma Company Information Table 99. Sun Pharma Business Overview Table 100. Sun Pharma Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Sun Pharma Capecitabine Tablets Product Portfolio Table 102. Sun Pharma Recent Development Table 103. Eugia Pharma Company Information Table 104. Eugia Pharma Business Overview Table 105. Eugia Pharma Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Eugia Pharma Capecitabine Tablets Product Portfolio Table 107. Eugia Pharma Recent Development Table 108. Dr. Reddy's Laboratories Company Information Table 109. Dr. Reddy's Laboratories Business Overview Table 110. Dr. Reddy's Laboratories Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Dr. Reddy's Laboratories Capecitabine Tablets Product Portfolio Table 112. Dr. Reddy's Laboratories Recent Development Table 113. Accord Healthcare Company Information Table 114. Accord Healthcare Business Overview Table 115. Accord Healthcare Capecitabine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Accord Healthcare Capecitabine Tablets Product Portfolio Table 117. Accord Healthcare Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Capecitabine Tablets Distributors List Table 121. Capecitabine Tablets Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Capecitabine Tablets Product Image Figure 2. Global Capecitabine Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Capecitabine Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Capecitabine Tablets Sales (2021-2032) & (K Units) Figure 5. Global Capecitabine Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Capecitabine Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 150mg Image Figure 9. 500mg Image Figure 10. Global Capecitabine Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Capecitabine Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Capecitabine Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Capecitabine Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Capecitabine Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Capecitabine Tablets Revenue Market Share by Type (2021-2032) Figure 16. Colon Cancer Image Figure 17. Breast Cancer Image Figure 18. Stomach Cancer Image Figure 19. Global Capecitabine Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Capecitabine Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Capecitabine Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Capecitabine Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Capecitabine Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Capecitabine Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Capecitabine Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Capecitabine Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Capecitabine Tablets Sales Market Share by Country (2021-2032) Figure 39. China Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Capecitabine Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Capecitabine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Capecitabine Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Capecitabine Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Capecitabine Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Capecitabine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Capecitabine Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Capecitabine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Capecitabine Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Capecitabine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Capecitabine Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Capecitabine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Capecitabine Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Capecitabine Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg
  • 500mg
Applications
  • Colon Cancer
  • Breast Cancer
  • Stomach Cancer
Companies covered
  • Chia Tai-Tianqing Pharmaceutical
  • Chengdu Easton Biopharmaceuticals
  • Shanghai Sine Pharmaceutical
  • Shandong New Time Pharmaceutical
  • Qilu Pharmaceutical
  • Roche
  • Teva Pharmaceutical
  • Sun Pharma
  • Eugia Pharma
  • Dr. Reddy's Laboratories
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Capecitabine Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Capecitabine Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Capecitabine Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Capecitabine Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Capecitabine Tablets Market Dynamics
  1. 2.1 Capecitabine Tablets Industry Trends
  2. 2.2 Capecitabine Tablets Industry Drivers
  3. 2.3 Capecitabine Tablets Industry Opportunities and Challenges
  4. 2.4 Capecitabine Tablets Industry Restraints
3 Capecitabine Tablets Market by Manufacturers
  1. 3.1 Global Capecitabine Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Capecitabine Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Capecitabine Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Capecitabine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Capecitabine Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Capecitabine Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Capecitabine Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Capecitabine Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Capecitabine Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Capecitabine Tablets Tier 1, Tier 2, and Tier 3
4 Capecitabine Tablets Market by Type
  1. 4.1 Capecitabine Tablets Type Introduction
  2. 4.1.1 150mg
  3. 4.1.2 500mg
  4. 4.2 Global Capecitabine Tablets Sales by Type
  5. 4.2.1 Global Capecitabine Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Capecitabine Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Capecitabine Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Capecitabine Tablets Revenue by Type
  9. 4.3.1 Global Capecitabine Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Capecitabine Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Capecitabine Tablets Revenue Market Share by Type (2021-2032)
5 Capecitabine Tablets Market by Application
  1. 5.1 Capecitabine Tablets Application Introduction
  2. 5.1.1 Colon Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Stomach Cancer
  5. 5.2 Global Capecitabine Tablets Sales by Application
  6. 5.2.1 Global Capecitabine Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Capecitabine Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Capecitabine Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Capecitabine Tablets Revenue by Application
  10. 5.3.1 Global Capecitabine Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Capecitabine Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Capecitabine Tablets Revenue Market Share by Application (2021-2032)
6 Global Capecitabine Tablets Sales by Region
  1. 6.1 Global Capecitabine Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Capecitabine Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Capecitabine Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Capecitabine Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Capecitabine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Capecitabine Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Capecitabine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Capecitabine Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Capecitabine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Capecitabine Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Capecitabine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Capecitabine Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Capecitabine Tablets Revenue by Region
  1. 7.1 Global Capecitabine Tablets Revenue by Region
  2. 7.1.1 Global Capecitabine Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Capecitabine Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Capecitabine Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Capecitabine Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Capecitabine Tablets Revenue (2021-2032)
  8. 7.2.2 North America Capecitabine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Capecitabine Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Capecitabine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Capecitabine Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Capecitabine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Capecitabine Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Capecitabine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chia Tai-Tianqing Pharmaceutical
  2. 8.1.1 Chia Tai-Tianqing Pharmaceutical Company Information
  3. 8.1.2 Chia Tai-Tianqing Pharmaceutical Business Overview
  4. 8.1.3 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product Portfolio
  6. 8.1.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
  7. 8.2 Chengdu Easton Biopharmaceuticals
  8. 8.2.1 Chengdu Easton Biopharmaceuticals Company Information
  9. 8.2.2 Chengdu Easton Biopharmaceuticals Business Overview
  10. 8.2.3 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product Portfolio
  12. 8.2.5 Chengdu Easton Biopharmaceuticals Recent Developments
  13. 8.3 Shanghai Sine Pharmaceutical
  14. 8.3.1 Shanghai Sine Pharmaceutical Company Information
  15. 8.3.2 Shanghai Sine Pharmaceutical Business Overview
  16. 8.3.3 Shanghai Sine Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Sine Pharmaceutical Capecitabine Tablets Product Portfolio
  18. 8.3.5 Shanghai Sine Pharmaceutical Recent Developments
  19. 8.4 Shandong New Time Pharmaceutical
  20. 8.4.1 Shandong New Time Pharmaceutical Company Information
  21. 8.4.2 Shandong New Time Pharmaceutical Business Overview
  22. 8.4.3 Shandong New Time Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shandong New Time Pharmaceutical Capecitabine Tablets Product Portfolio
  24. 8.4.5 Shandong New Time Pharmaceutical Recent Developments
  25. 8.5 Qilu Pharmaceutical
  26. 8.5.1 Qilu Pharmaceutical Company Information
  27. 8.5.2 Qilu Pharmaceutical Business Overview
  28. 8.5.3 Qilu Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qilu Pharmaceutical Capecitabine Tablets Product Portfolio
  30. 8.5.5 Qilu Pharmaceutical Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roche Capecitabine Tablets Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 Teva Pharmaceutical
  38. 8.7.1 Teva Pharmaceutical Company Information
  39. 8.7.2 Teva Pharmaceutical Business Overview
  40. 8.7.3 Teva Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceutical Capecitabine Tablets Product Portfolio
  42. 8.7.5 Teva Pharmaceutical Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Capecitabine Tablets Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
  49. 8.9 Eugia Pharma
  50. 8.9.1 Eugia Pharma Company Information
  51. 8.9.2 Eugia Pharma Business Overview
  52. 8.9.3 Eugia Pharma Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eugia Pharma Capecitabine Tablets Product Portfolio
  54. 8.9.5 Eugia Pharma Recent Developments
  55. 8.10 Dr. Reddy's Laboratories
  56. 8.10.1 Dr. Reddy's Laboratories Company Information
  57. 8.10.2 Dr. Reddy's Laboratories Business Overview
  58. 8.10.3 Dr. Reddy's Laboratories Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dr. Reddy's Laboratories Capecitabine Tablets Product Portfolio
  60. 8.10.5 Dr. Reddy's Laboratories Recent Developments
  61. 8.11 Accord Healthcare
  62. 8.11.1 Accord Healthcare Company Information
  63. 8.11.2 Accord Healthcare Business Overview
  64. 8.11.3 Accord Healthcare Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Accord Healthcare Capecitabine Tablets Product Portfolio
  66. 8.11.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Capecitabine Tablets Value Chain Analysis
  2. 9.1.1 Capecitabine Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Capecitabine Tablets Production Mode & Process
  6. 9.2 Capecitabine Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Capecitabine Tablets Distributors
  9. 9.2.3 Capecitabine Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst